Shanghai SIMR Biotech 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 
  • ||||||||||  SR1375 / Shanghai SIMR Biotech
    Trial completion:  A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SR1375 (clinicaltrials.gov) -  Nov 22, 2023   
    P1,  N=72, Completed, 
    In the subgroup of patients with concomitant interstitial pulmonary fibrosis, there was a trend towards a more pronounced therapeutic improvement in the 7-category ordinal scale (-0.44 vs -0.23, p=0.05). Active, not recruiting --> Completed
  • ||||||||||  SR1375 / Shanghai SIMR Biotech
    Trial completion, Trial completion date, Trial primary completion date:  The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers (clinicaltrials.gov) -  Feb 10, 2023   
    P1,  N=32, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2023 --> Oct 2022 | Trial primary completion date: Mar 2023 --> Oct 2022
  • ||||||||||  SR750 / Shanghai SIMR Biotech
    Trial completion, Trial completion date, Trial primary completion date:  The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers (clinicaltrials.gov) -  Feb 10, 2023   
    P1,  N=83, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Mar 2023 --> Oct 2022 | Trial primary completion date: Mar 2023 --> Oct 2022 Active, not recruiting --> Completed | Trial completion date: Mar 2023 --> Oct 2022 | Trial primary completion date: Mar 2023 --> Oct 2022
  • ||||||||||  SR750 / Shanghai SIMR Biotech
    Trial primary completion date:  The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers (clinicaltrials.gov) -  Feb 8, 2023   
    P1,  N=83, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Mar 2023 --> Oct 2022 | Trial primary completion date: Mar 2023 --> Oct 2022 Trial primary completion date: Dec 2022 --> Mar 2023
  • ||||||||||  SR1375 / Shanghai SIMR Biotech
    Enrollment closed, Trial completion date, Trial primary completion date:  The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers (clinicaltrials.gov) -  Dec 14, 2022   
    P1,  N=32, Active, not recruiting, 
    Trial completion date: Oct 2022 --> Jan 2023 Recruiting --> Active, not recruiting | Trial completion date: Oct 2022 --> Mar 2023 | Trial primary completion date: Sep 2022 --> Jan 2023
  • ||||||||||  SR750 / Shanghai SIMR Biotech
    Enrollment closed, Trial completion date:  The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers (clinicaltrials.gov) -  Dec 14, 2022   
    P1,  N=83, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial completion date: Oct 2022 --> Mar 2023 | Trial primary completion date: Sep 2022 --> Jan 2023 Recruiting --> Active, not recruiting | Trial completion date: Dec 2022 --> Mar 2023
  • ||||||||||  SR419 / Shanghai SIMR Biotech
    Enrollment closed, Trial completion date:  To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN) (clinicaltrials.gov) -  Nov 30, 2022   
    P2,  N=83, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial completion date: Dec 2022 --> Mar 2023 Recruiting --> Active, not recruiting | Trial completion date: Jul 2023 --> Jan 2023
  • ||||||||||  SR750 / Shanghai SIMR Biotech
    Trial completion date, Trial primary completion date:  The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers (clinicaltrials.gov) -  Sep 7, 2022   
    P1,  N=72, Recruiting, 
    Recruiting --> Active, not recruiting | Trial completion date: Jul 2023 --> Jan 2023 Trial completion date: May 2022 --> Dec 2022 | Trial primary completion date: May 2022 --> Oct 2022
  • ||||||||||  SR419 / Shanghai SIMR Biotech
    Trial completion, Trial completion date, Trial primary completion date:  A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (clinicaltrials.gov) -  Aug 5, 2022   
    P1b,  N=24, Completed, 
    Active, not recruiting --> Recruiting Recruiting --> Completed | Trial completion date: Dec 2021 --> Jul 2022 | Trial primary completion date: Dec 2021 --> May 2022
  • ||||||||||  SR419 / Shanghai SIMR Biotech
    Trial completion date:  The Pharmacokinetics (PK), Safety, Tolerability of SR419 in Healthy Volunteers (clinicaltrials.gov) -  Aug 3, 2022   
    P1,  N=40, Completed, 
    Recruiting --> Completed | Trial completion date: Dec 2021 --> Jul 2022 | Trial primary completion date: Dec 2021 --> May 2022 Trial completion date: Dec 2021 --> May 2022